Pharma conference examines MHRA, VPAS, staffing and real estate needs

Four important themes for the life sciences were the focus of the Professional Industry Network Group (PING) conference, held in June 2023. These included the position of the Medicines and Healthcare products Regulatory Agency (MHRA) post the COVID-19 pandemic, the implications of the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and the proposed Voluntary Scheme for Pricing, Access and Growth (VPAG), plus whether there were adequate staffing and premises to support the sector.